Naoki Okada

Dr. Naoki Okada

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Biomaterials
Verified
Journal Article
Closed access
SHSachiko Hirobe
Sachiko Hirobe
HAHiroaki Azukizawa
Hiroaki Azukizawa
THTakaaki Hanafusa
Takaaki Hanafusa
KMKazuhiko Matsuo
Kazuhiko Matsuo
YQYing-Shu Quan
Ying-Shu Quan
SNShinsaku Nakagawa
Shinsaku Nakagawa

9 May 2020 in Cells
Verified
Journal Article
Open access
PDF file
KFKento Fujiwara
Kento Fujiwara
ATAyaka Tsunei
Ayaka Tsunei
HKHotaka Kusabuka
Hotaka Kusabuka
EOErika Ogaki
Erika Ogaki
MTMasashi Tachibana
Masashi Tachibana
NONaoki Okada
Naoki Okada
Chimeric antigen receptor (CAR)-T cells have demonstrated significant clinical potential; however, their strong antitumor activity may cause severe adverse effects. To ensure efficacy and safe CAR-T cell therapy, it is important to understand CAR’s structure–activity relationship. To clarify the role of hinge and transmembrane domains in CAR and CAR-T cell function, we generated different chimeras and analyzed their expression levels and antigen-specific activity on CAR-T cells. First, we created a basic CAR with hinge, transmembrane, and signal transduction domains derived from CD3ζ, then we generated six CAR variants whose hinge or hinge/transmembrane domains originated from CD4, CD8α, and CD28. CAR expression level and stability on the T cell were greatly affected by transmembrane rather than hinge domain. Antigen-specific functions of most CAR-T cells depended on their CAR expression levels. However, CARs with a CD8α- or CD28-derived hinge domain showed significant differences in CAR-T cell function, despite their equal expression levels. These results suggest that CAR signaling intensity into T cells was affected not only by CAR expression level, but also by the hinge domain. Our discoveries indicate that the hinge domain regulates the CAR signaling threshold and the transmembrane domain regulates the amount of CAR signaling via control of CAR expression level.

18 June 2013 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
SHSachiko Hirobe
Sachiko Hirobe
HAHiroaki Azukizawa
Hiroaki Azukizawa
KMKazuhiko Matsuo
Kazuhiko Matsuo
YZYou Zhai
You Zhai
YQYing-Shu Quan
Ying-Shu Quan
SNShinsaku Nakagawa
Shinsaku Nakagawa

1 June 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KFKento Fujiwara
Kento Fujiwara
MMMizuki Masutani
Mizuki Masutani
MTMasashi Tachibana
Masashi Tachibana
NONaoki Okada
Naoki Okada

1 October 2008 in Journal of Controlled Release
Verified
Journal Article
Closed access
YIYumiko Ishii
Yumiko Ishii
TNTomoko Nakae
Tomoko Nakae
FSFumiko Sakamoto
Fumiko Sakamoto
KMKazuhiko Matsuo
Kazuhiko Matsuo
KMKeisuke Matsuo
Keisuke Matsuo
NONaoki Okada
Naoki Okada

1 May 2013 in Vaccine
Verified
Journal Article
Closed access
KMKazuhiko Matsuo
Kazuhiko Matsuo
SHSachiko Hirobe
Sachiko Hirobe
NONaoki Okada
Naoki Okada
SNShinsaku Nakagawa
Shinsaku Nakagawa